KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $132.4 million.

  • Chemed's Non-Current Deffered Revenue rose 829.52% to $132.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.4 million, marking a year-over-year increase of 829.52%. This contributed to the annual value of $126.0 million for FY2024, which is 2110.72% up from last year.
  • Chemed's Non-Current Deffered Revenue amounted to $132.4 million in Q3 2025, which was up 829.52% from $127.7 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Non-Current Deffered Revenue registered a high of $132.4 million during Q3 2025, and its lowest value of $89.9 million during Q3 2022.
  • Over the past 5 years, Chemed's median Non-Current Deffered Revenue value was $100.8 million (recorded in 2022), while the average stood at $107.6 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 3324.47% in 2021, then crashed by 1049.31% in 2022.
  • Quarter analysis of 5 years shows Chemed's Non-Current Deffered Revenue stood at $98.6 million in 2021, then dropped by 6.36% to $92.3 million in 2022, then grew by 12.71% to $104.1 million in 2023, then increased by 21.11% to $126.0 million in 2024, then increased by 5.03% to $132.4 million in 2025.
  • Its Non-Current Deffered Revenue was $132.4 million in Q3 2025, compared to $127.7 million in Q2 2025 and $127.3 million in Q1 2025.